Xuekun JIN

Mr Jin Xuekun, Chief Executive Officer and Executive Director, BloomageBioTechnology Corporation Limited BloomageBioTechnology is an international corporation dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid and focuses mainly on the development, manufacture and sale of various HA raw materials and end products. It has been listed in the Stock Exchange of Hong Kong with the stock code 00963. Currently, Mr. Jin serves as Chief Executive Officer and Executive Director in BloomageBioTechnology based in Beijing. Prior to that, Mr. Jin worked as Head of China in Esaote Group, one of the world’s leading producers of medical diagnostic systems, mainly focusing on its strategic management, business innovation and cultural construction.Mr. Jin has accumulated extensive experiences with a more than twenty-year tenure in multinational corporations in China, dedicating to the marketing and sales of medical devices with international brands. He possesses many profound and original insights in terms of multinational resources integration, construction of overseas platform, internal process design and optimization and etc. Mr. Jin studied in the MBA program of China Center for Economic Research in Peking University, and holds the MBA degree from Fordham University.